Orthopedic Biomaterials Market 2024 | Market Size, Key Drivers, Industry Developments, Share, Future Growth Prospects And Forecast To 2033

Global orthopedic biomaterials market size is expected to reach $34.03 Bn by 2028 at a rate of 13.5%, segmented as by material type, ceramics & bioactive glasses, calcium phosphate cements, polymers, metal, composites

Jul 9, 2024 - 17:48

Overview and Scope

Orthopedic biomaterials are materials intended to be inserted into the human body as constituents of devices designed to perform certain biological functions by either substituting or repairing various tissues, such as bones, cartilage, ligaments, tendons, and others.

Sizing and Forecast
The orthopedic biomaterials market size has grown rapidly in recent years. It will grow from $18.62 billion in 2023 to $20.51 billion in 2024 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to advancement in technologies, and rise in healthcare expenditure, growth in the number of healthcare facilities and economic growth .

The orthopedic biomaterials market size is expected to see rapid growth in the next few years. It will grow to $34.03 billion in 2028 at a compound annual growth rate (CAGR) of 13.5%. The growth in the forecast period can be attributed to increased prevalence of obesity and arthritis conditions, rapid growth in the geriatric population and increase in joint replacement surgical procedures . Major trends in the forecast period include manufacturing implants using 3d printing technology, developing new innovative products, developing smart biomaterials implants, and on merger and acquisition activities. player-adopted strategies in the orthopedic biomaterials market include investing in expanding operations through innovative product launches, and in acquisitions and mergers to strengthen their service offerings.

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/orthopedic-biomaterials-global-market-report

Segmentation & Regional Insights
The orthopedic biomaterials market covered in this report is segmented –

1) By Material Type: Ceramics & Bioactive Glasses, Calcium Phosphate Cements, Polymers, Metal, Composites
2) By Application: Orthopedic Implants, Joint Replacement/Reconstruction, Bio-Resorbable Tissue Fixation, Other Applications
3) By End-User: Hospitals, Clinics, Other End-Users

North America was the largest region in the orthopedic biomaterials market in 2023. Western Europe was the second largest region in the orthopedic biomaterials market report. The regions covered in the orthopedic biomaterials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3239&type=smp

Major Driver Impacting Market Growth
The rise in the incidence of musculoskeletal disorders is expected to drive the orthopedic biomaterials market. According to the World Health Organization (WHO) report, musculoskeletal conditions are the leading contributor to disability worldwide. About 20-33% of the population suffer from a musculoskeletal disability. Musculoskeletal disorders induce fractures, swelling, and discomfort in the joints, ligaments, and tendons that cause movement disabilities. The burden of musculoskeletal conditions is known to increase with age. The sustainable development goals (SDGs) and the Decade of Healthy Ageing 2020–2030 have called for increased global attention and action on musculoskeletal health. Biomaterials are used to treat these disorders. Hence, the incidence of musculoskeletal disorders is projected to drive the orthopedic biomaterials market.

Key Industry Players
Major companies operating in the orthopedic biomaterials market report are Zimmer Biomet Holdings, Stryker Corporation, Johnson & Johnson, Smith & Nephew plc, Globus Medical Inc., Exactech Inc., Heraeus Holding GmbH, Evonik Industries AG, Victrex plc., Collagen Matrix Inc., Royal DSM, Sahajanand Medical Technologies, SCHILLER Healthcare India Pvt. Ltd., GE Healthcare, Covidien Healthcare India Private Limited, Philips Healthcare India, Fisher & Paykel Healthcare India Private Limited, Smiths Medical India Pvt. Ltd, Agappe Diagnostics Ltd, ARKRAY Healthcare Pvt. Ltd, Accord Medical Products Private Limited, AAP Implantate AG, Waldemar Link GmbH & Co. KG, Amplitude SAS, Corin Group PLC, Beznoska Company Ltd, Sanatmetal Ltd, Medin a.s., Neoortho, Amplitude Ortho, Cremer S. A., BSN Medical SA, Corin South Africa, Draegerwerk AG, ResMed Inc

The orthopedic biomaterials market report table of contents includes:

1. Executive Summary

2. Orthopedic Biomaterials Market Characteristics

3. Orthopedic Biomaterials Market Trends And Strategies

4. Orthopedic Biomaterials Market - Macro Economic Scenario

5. Global Orthopedic Biomaterials Market Size and Growth

.....

32. Global Orthopedic Biomaterials Market Competitive Benchmarking

33. Global Orthopedic Biomaterials Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Orthopedic Biomaterials Market

35. Orthopedic Biomaterials Market Future Outlook and Potential Analysis

36. Appendix